RAP2B and cancer: Interestingly, regarding the impact of Rap2b levels on patient survival, the analysis indicated that a high level of Rap2b is negatively correlated with the survival of cancer patients in the CMS1–3 categories (p = 0.02 in CMS1), but not in CMS4 (Fig. S9C).